Ignite Creation Date:
2025-12-24 @ 9:14 PM
Ignite Modification Date:
2026-01-25 @ 6:08 AM
Study NCT ID:
NCT04743804
Status:
TERMINATED
Last Update Posted:
2024-10-01
First Post:
2021-01-28
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Ravulizumab in Thrombotic Microangiopathy Associated With a Trigger
Sponsor:
Alexion Pharmaceuticals, Inc.
Organization: